Riskpilot← Back to searchSign inGet full accessPharmacosweden AB
ABActiveOrg 5568767890Wholesale of pharmaceutical and medical goods · NACE 4646Est. 201110-19 employees
Revenue 2025
SEK 22,1M
+28% vs 2024
EBITDA margin
8.4%
+22% vs 2024
Equity ratio
60.0%
Financial strength
Net profit 2025
SEK 503K
+6% vs 2024
| Revenue | SEK 22,1M | +28% |
| EBITDA | SEK 1,9M | +22% |
| Net profit | SEK 503K | +6% |
| Total assets | SEK 9,8M | +14% |
| Equity | SEK 5,9M | +9% |
| Employees | — | — |
Legal name
Pharmacosweden AB
Org number
5568767890
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
16 december 2011
Share capital
SEK 100 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva försäljning och marknadsföring av handel med pharmaceutiska produkter och närliggande områden och bedriva därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 10 716 | 15 225 | 16 521 | 17 295 | 22 119 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 923 | 1 132 | 1 353 | 1 525 | 1 863 |
| Depreciation & amort. | −425 | −434 | −566 | −711 | −998 |
| EBIT | 498 | 698 | 787 | 814 | 865 |
| Net financials | — | — | 2 | 5 | −7 |
| Profit before tax | 497 | 698 | 788 | 820 | 858 |
| Tax | −122 | −196 | −274 | −344 | −355 |
| Net profit | 375 | 502 | 514 | 476 | 503 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 6 119 | 7 379 | 8 153 | 8 626 | 9 820 |
| Equity | 3 894 | 4 396 | 4 910 | 5 387 | 5 890 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 225 | 2 982 | 3 242 | 3 239 | 3 930 |
| Total debt | 2 225 | 2 982 | 3 242 | 3 239 | 3 930 |
EBITDA margin
8.4%
This company
15.8%
Market median
-47% vs market
20212025
Equity ratio
60.0%
This company
38.2%
Market median
+57% vs market
20212025
Return on equity
8.5%
This company
18.4%
Market median
-54% vs market
20212025
Net profit margin
2.3%
This company
8.1%
Market median
-72% vs market
20212025
Asset turnover
2.25×
This company
1.12×
Market median
+101% vs market
20212025
Debt / equity
0.67×
This company
0.62×
Market median
+8% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JM | Audit | 2025 |
| Former (2) | ||
BD Authorized Recipient of Service | Authorized Recipient of Service | 2022 – 2024 |
EU Authorized Recipient of Service | Authorized Recipient of Service | 2024 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Deputy Board Member | 2024 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2024 | |
| Board of Directors | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PHARMACOSMOS A/S
Pharmacosweden AB (this company)Board members of Pharmacosweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bob David Johanson | Authorized Recipient of Service | 0 companies |
| Jacob Magnus Kvarnhammar | Audit | 0 companies |
| Elisabeth Ulrika Eklund | Authorized Recipient of Service | 0 companies |
| Robert Guglielmetti | Deputy Board Member | 0 companies |
| Henrik Parker Mathisson | Board of Directors | 0 companies |
| Lars Christensen | Board of Directors | 0 companies |
| Ester Malin Maria Winterleijon | Deputy Board Member | 0 companies |